Transcept announces layoffs

Share this article:

Transcept Pharmaceuticals—known for its sleep drug Intermezzo—is cutting 43% of its workforce.

The company announced Tuesday that six employees will be laid off between now and early 2014, leaving a staff of eight.

The layoffs are part of a larger restructuring that includes reorganizing its board of directors.

The company's lead pipeline product, TO-2070, is for acute migraines.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.